Amendment and Mail Process Complete

INDEX

Elysium Health, Inc.

Amendment and Mail Process Complete

Trademark Snap Shot Amendment & Mail Processing Stylesheet
(Table presents the data on Amendment & Mail Processing Complete)

OVERVIEW

SERIAL NUMBER 88621038 FILING DATE 09/18/2019
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY TM ATTORNEY NOT ASSIGNED L.O. ASSIGNED NONE

PUB INFORMATION

RUN DATE 10/18/2019
PUB DATE N/A
STATUS 630-NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
STATUS DATE 09/25/2019
LITERAL MARK ELEMENT INDEX

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT INDEX
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME Elysium Health, Inc.
ADDRESS 434 Broadway, Floor 2
New York, NY 10013
ENTITY 03-CORPORATION
CITIZENSHIP Delaware

GOODS AND SERVICES

INTERNATIONAL CLASS 009
          DESCRIPTION TEXT Kits for use in epigenetic testing for scientific and research purposes comprising a saliva collection tube, caps for tube, and mailing packaging for use in DNA testing of humans
INTERNATIONAL CLASS 010
          DESCRIPTION TEXT Kits for use in epigenetic testing for medical purposes comprising a saliva collection tube, caps for tube, and mailing packaging for use in DNA testing of humans
INTERNATIONAL CLASS 042
          DESCRIPTION TEXT Providing scientific analysis and informational reports based upon results of laboratory testing in the field of epigenetics; scientific research in the fields of epigenetics

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 009 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 010 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 042 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
10/17/2019 AMPX O APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED 005
10/12/2019 ALIE A ASSIGNED TO LIE 004
10/08/2019 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED 003
09/25/2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
09/21/2019 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Michael R. Rizzo
CORRESPONDENCE ADDRESS MICHAEL R. RIZZO
SAUNDERS & SILVERSTEIN LLP
14 CEDAR STREET, SUITE 224
AMESBURY, MA 01913
DOMESTIC REPRESENTATIVE NONE

Amendment and Mail Process Complete [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed